As shown in Figure1A, the c-MYC expression level in surgically resected primary colorectal cancer tissues of patients with recurrence following 5-FU-based adjuvant chemotherapy was significantly higher than that of patients without recurrence (P = 0.002). This evidence concerns the gene MYC and colorectal cancer.